The clinical potential of gene editing as a tool to engineer cell‐based therapeutics-Reference-Cited by-同舟云学术

The clinical potential of gene editing as a tool to engineer cell‐based therapeutics

Published:2020-01 Issue:1 Volume:9 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical and Translational Medicine

Author:

Ashmore‐Harris Candice¹²,Fruhwirth Gilbert O.¹^ORCID

Affiliation:

1. Imaging Therapy and Cancer GroupDept of Imaging Chemistry & BiologySchool of Biomedical Engineering & Imaging SciencesSt Thomas’ HospitalKing's College London (KCL)SE1 7EHLondonUK

2. Centre for Stem Cells & Regenerative MedicineSchool of Basic and Medical BiosciencesGuy's HospitalKCLSE1 9RTLondonUK

Funder

Cancer Research UK

CR-UK

Wellcome Trust

Engineering and Physical Sciences Research Council

Guy’s & St. Thomas’ Charity

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1186/s40169-020-0268-z

Reference167 articles.

1. Mesenchymal Stem Cells: Time to Change the Name!

2. The translation of cell-based therapies: clinical landscape and manufacturing challenges

3. Bioinformant cell therapy industry database.https://bioinformant.com/product/cell‐therapy‐industry‐database/. Accessed 3 Oct 2019

4. Cell, tissue and gene products with marketing authorization in 2018 worldwide

5. KrekorianM FruhwirthGO SrinivasMet al (2019)Imaging of T‐cells and their responses during anti‐cancer immunotherapy. Theranostics.https://doi.org/10.7150/thno.37924

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nuclear-Based Labeling of Cellular Immunotherapies: A Simple Protocol for Preclinical Use;Molecular Imaging and Biology;2024-07-03

2. Cluster of differentiation molecules in the metabolic syndrome;Clinica Chimica Acta;2024-07

3. Exploiting in silico modelling to enhance translation of liver cell therapies from bench to bedside;npj Regenerative Medicine;2024-05-09

4. Nuclear-based labeling of cellular immunotherapies: a simple protocol for preclinical use;2024-01-30

5. Molecular prospects of transcription activator-like effector nucleases (TALENs) in cancer management: Challenges and adaptations;Biomarkers in Cancer Detection and Monitoring of Therapeutics;2024